# Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus

> **NCT00003054** · PHASE2 · TERMINATED · sponsor: **Gynecologic Oncology Group**

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00003054
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1997-08
- **Primary completion:** 2002-07
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2018-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003054, "Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00003054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*